← Open Payments lookup

CANDACE LANKFORD: Open Payments

NPI 1134751530 · FRANKLIN, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,553 in 80 payments from 13 companies in 2025. Trend: 2023 $1,769 · 2024 $1,575 · 2025 $1,553

Food & beverage: $1,553
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.20$420
ABBVIE INC.18$282
Otsuka America Pharmaceutical, Inc.11$220
Janssen Pharmaceuticals, Inc7$181
Supernus Pharmaceuticals, Inc.5$85
Neurocrine BioSciences, Inc.4$82
Alkermes, Inc.3$66
Takeda Pharmaceuticals U.S.A., Inc.3$56
Teva Pharmaceuticals USA, Inc.3$43
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$42

Products named: COBENFY, VRAYLAR, REXULTI, INVEGA SUSTENNA, Qelbree, INGREZZA, ARISTADA, ABILIFY ASIMTUFII.

Industry payments across VA — which companies pay providers there.